María Ángeles
Serrano García
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (2)
2019
-
Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib
British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800
2002
-
Evidence for dual effects of DNA-reactive bile acid derivatives (Bamets) on hepatitis B virus life cycle in an in vitro replicative system
Antiviral Chemistry and Chemotherapy, Vol. 13, Núm. 6, pp. 371-380